The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Ron Waksman
Showing 1-20 of 44 articles
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study
Haude M,
Wlodarczak A,
van der Schaaf R,
Torzewski J,
Ferdinande B,
Escaned J,
Iglesias JF,
Bennett J,
Toth GG,
Joner M,
Toelg R,
Wiemer M,
Olivecrano G,
Vermeersch P,
Garcia-Garcia H,
Waksman R
August 7, 2023 | 10.4244/EIJ-D-23-00326
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M,
Baumann-Zumstein P,
Fubel A,
Waksman R,
Haude M,
Galli S,
Joner M
June 5, 2023 | 10.4244/EIJ-D-22-00718
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial
Slagboom T,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematus M,
Takahashi A,
Waksman R,
Saito S
February 20, 2023 | 10.4244/EIJ-D-22-00526
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G,
Soria Jimenez CE,
Torguson R,
Case BC,
Forrestal B,
Ali S,
Shea C,
Zhang C,
Wang J,
Gordon P,
Ehsan A,
Wilson SR,
Levitt R,
Parikh P,
Bilfinger T,
Hanna N,
Buchbinder M,
Asch FM,
Weissman G,
Shults C,
Garcia-Garcia H,
Ben-Dor I,
Satler L,
Waksman R,
Rogers T
August 5, 2022 | 10.4244/EIJ-D-21-01091
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE)
Räber L,
Häner JD,
Lüscher T,
Moccetti M,
Roffi M,
Stortecky S,
Muller O,
Garcia-Garcia H,
Waksman R,
Siegrist P
June 3, 2022 | 10.4244/EIJ-D-21-00537
Lipid-rich plaque density and low-density lipoprotein cholesterol in statin-treated versus statin-naïve patients: a post hoc analysis of the LRP study
Torguson R,
Mintz GS,
Zhang C,
Case BC,
Di Mario C,
Garcia-Garcia H,
Waksman R
May 15, 2022 | 10.4244/EIJ-D-21-00701
Scaffold thrombosis: what is to blame?
Waksman R,
Bhogal S
December 17, 2021 | 10.4244/EIJV17I12A159
High bleeding risk patients: one size does not fit all
Waksman R,
Yerasi C
June 25, 2021 | 10.4244/EIJV17I3A35
Entrapment of the Impella heart pump in the mitral subvalvular apparatus
Khalid N,
Shlofmitz E,
Case BC,
Waksman R
February 5, 2021 | 10.4244/EIJ-D-19-00942
Adverse events with orbital atherectomy: an analytic review of the MAUDE database
Khalid N,
Javed H,
Rogers T,
Hashim H,
Shlofmitz E,
Wermers J,
Chen Y,
Musallam A,
Khan JM,
Torguson R,
Bernardo N,
Waksman R
July 17, 2020 | 10.4244/EIJ-D-19-00295
Bioresorbable scaffolds: did we jump the gun?
Waksman R,
Forrestal B
June 12, 2020 | 10.4244/EIJV16I2A16
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Haude M,
Ince H,
Toelg R,
Lemos P,
von Birgelen C,
Christiansen E,
Wijns W,
Neumann F,
Eeckhout E,
Garcia-Garcia H,
Waksman R
February 7, 2020 | 10.4244/EIJ-D-18-01000
BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months
Saito S,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematsu M,
Takahashi A,
Waksman R,
Slagboom T
December 6, 2019 | 10.4244/EIJ-D-18-01214
Reply to the letter to the editor “Impella device use in high-risk PCI”
Khalid N,
Rogers T,
Shlofmitz E,
Chen Y,
Waksman R
October 18, 2019 | 10.4244/EIJ-D-19-00279R
Paclitaxel-coated balloons and stents for the treatment of peripheral artery disease: proceedings from the Cardiovascular Research Technologies (CRT) 2019 Town Hall
Dan K,
Garcia-Garcia H,
Hideo-Kajita A,
Zhang C,
Wermers J,
Kolm P,
Torguson R,
Waksman R
July 19, 2019 | 10.4244/EIJV15I4A59
Paclitaxel-coated balloons and stents for the treatment of peripheral artery disease: proceedings from the Cardiovascular Research Technologies (CRT) 2019 Town Hall
Dan K,
Garcia-Garcia H,
Hideo-Kajita A,
Zhang C,
Wermers J,
Kolm P,
Torguson R,
Waksman R
June 13, 2019 | 10.4244/EIJY19M06_1
Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: a retrospective analysis of the MAUDE database
Khalid N,
Rogers T,
Shlofmitz E,
Chen Y,
Khan JM,
Musallam A,
Iantorno M,
Waksman R
May 20, 2019 | 10.4244/EIJ-D-18-01021
Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model
Lipinski M,
Acampado E,
Cheng Q,
Adams L,
Torii S,
Gai J,
Torguson R,
Hellinga DG,
Joner M,
Harder C,
Zumstein P,
Finn AV,
Kolodgie F,
Virmani R,
Waksman R
January 18, 2019 | 10.4244/EIJ-D-17-00958
Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds
Joner M,
Ruppelt P,
Zumstein P,
Lapointe-Corriveau C,
Leclerc G,
Bulin A,
Castellanos M,
Wittchow E,
Haude M,
Waksman R
October 12, 2018 | 10.4244/EIJ-D-17-00708
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude M,
Ince H,
Kische S,
Abizaid A,
Toelg R,
Lemos P,
Van Mieghem NM,
Verheye S,
von Birgelen C,
Christiansen E,
Wijns W,
Garcia-Garcia H,
Waksman R
July 20, 2017 | 10.4244/EIJ-D-17-00254
1
2
3
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023